Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)
CNY 6.97
(-0.29%)
CNY 6.97
(-0.29%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.77 Billion CNY | -5.35% |
| 2022 | 1.88 Billion CNY | 45.24% |
| 2021 | 1.29 Billion CNY | -2.21% |
| 2020 | 1.32 Billion CNY | 117.75% |
| 2019 | 607.89 Million CNY | 139.91% |
| 2018 | -1.52 Billion CNY | -282.24% |
| 2017 | 835.82 Million CNY | -48.19% |
| 2016 | 1.61 Billion CNY | 11.84% |
| 2015 | 1.44 Billion CNY | 182.35% |
| 2014 | 510.85 Million CNY | 255.27% |
| 2013 | 143.79 Million CNY | -36.1% |
| 2012 | 225.01 Million CNY | 12.31% |
| 2011 | 200.35 Million CNY | 8.01% |
| 2010 | 185.49 Million CNY | 36.73% |
| 2009 | 135.66 Million CNY | 29.46% |
| 2008 | 104.79 Million CNY | 28.15% |
| 2007 | 81.76 Million CNY | 61.24% |
| 2006 | 50.71 Million CNY | -1.04% |
| 2005 | 51.24 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 756.81 Million CNY | 9411.15% |
| 2024 Q3 | 597 Million CNY | 23.35% |
| 2024 Q2 | 483.98 Million CNY | -36.05% |
| 2023 Q4 | -8.12 Million CNY | -101.48% |
| 2023 Q3 | 548.6 Million CNY | 5.41% |
| 2023 Q2 | 520.43 Million CNY | -27.57% |
| 2023 FY | 1.77 Billion CNY | -5.35% |
| 2023 Q1 | 718.56 Million CNY | 160.09% |
| 2022 Q2 | 513.03 Million CNY | -6.39% |
| 2022 FY | 1.88 Billion CNY | 45.24% |
| 2022 Q4 | 276.27 Million CNY | -49.1% |
| 2022 Q1 | 548.03 Million CNY | 639.06% |
| 2022 Q3 | 542.73 Million CNY | 5.79% |
| 2021 FY | 1.29 Billion CNY | -2.21% |
| 2021 Q2 | 484.38 Million CNY | 13.69% |
| 2021 Q1 | 426.04 Million CNY | 86.76% |
| 2021 Q4 | -101.66 Million CNY | -120.93% |
| 2021 Q3 | 485.74 Million CNY | 0.28% |
| 2020 FY | 1.32 Billion CNY | 117.75% |
| 2020 Q4 | 228.12 Million CNY | -42.81% |
| 2020 Q1 | 310.66 Million CNY | 15879.44% |
| 2020 Q2 | 386.05 Million CNY | 24.27% |
| 2020 Q3 | 398.86 Million CNY | 3.32% |
| 2019 Q1 | 218.82 Million CNY | 197.0% |
| 2019 FY | 607.89 Million CNY | 139.91% |
| 2019 Q4 | 1.94 Million CNY | -98.99% |
| 2019 Q3 | 192.96 Million CNY | -0.62% |
| 2019 Q2 | 194.16 Million CNY | -11.27% |
| 2018 Q1 | -689.32 Million CNY | -560.8% |
| 2018 Q3 | -445.68 Million CNY | -182.43% |
| 2018 Q2 | -157.8 Million CNY | 77.11% |
| 2018 Q4 | -225.57 Million CNY | 49.39% |
| 2018 FY | -1.52 Billion CNY | -282.24% |
| 2017 Q4 | -104.31 Million CNY | -145.1% |
| 2017 Q2 | 486.6 Million CNY | 118.97% |
| 2017 Q1 | 222.22 Million CNY | -41.47% |
| 2017 FY | 835.82 Million CNY | -48.19% |
| 2017 Q3 | 231.3 Million CNY | -52.47% |
| 2016 Q2 | 336.22 Million CNY | 7.65% |
| 2016 Q3 | 584.91 Million CNY | 73.97% |
| 2016 Q4 | 379.69 Million CNY | -35.09% |
| 2016 FY | 1.61 Billion CNY | 11.84% |
| 2016 Q1 | 312.31 Million CNY | 13.68% |
| 2015 Q3 | 336.13 Million CNY | -25.78% |
| 2015 Q4 | 274.74 Million CNY | -18.27% |
| 2015 Q2 | 452.87 Million CNY | 19.6% |
| 2015 Q1 | 378.66 Million CNY | 97.5% |
| 2015 FY | 1.44 Billion CNY | 182.35% |
| 2014 Q1 | 66.05 Million CNY | 1543.41% |
| 2014 Q3 | 145.53 Million CNY | 35.34% |
| 2014 FY | 510.85 Million CNY | 255.27% |
| 2014 Q4 | 191.72 Million CNY | 31.74% |
| 2014 Q2 | 107.53 Million CNY | 62.8% |
| 2013 Q4 | -4.57 Million CNY | -107.33% |
| 2013 FY | 143.79 Million CNY | -36.1% |
| 2013 Q3 | 62.46 Million CNY | -1.6% |
| 2013 Q2 | 63.47 Million CNY | 183.0% |
| 2013 Q1 | 22.43 Million CNY | -72.95% |
| 2012 Q1 | 21.31 Million CNY | -65.22% |
| 2012 Q2 | 46.1 Million CNY | 116.29% |
| 2012 Q3 | 74.66 Million CNY | 61.97% |
| 2012 Q4 | 82.92 Million CNY | 11.06% |
| 2012 FY | 225.01 Million CNY | 12.31% |
| 2011 Q3 | 59.05 Million CNY | 2.39% |
| 2011 Q2 | 57.67 Million CNY | 158.3% |
| 2011 Q1 | 22.32 Million CNY | -63.8% |
| 2011 FY | 200.35 Million CNY | 8.01% |
| 2011 Q4 | 61.28 Million CNY | 3.78% |
| 2010 Q3 | 53.32 Million CNY | 8.75% |
| 2010 FY | 185.49 Million CNY | 36.73% |
| 2010 Q2 | 49.03 Million CNY | 128.46% |
| 2010 Q1 | 21.46 Million CNY | -59.34% |
| 2010 Q4 | 61.67 Million CNY | 15.66% |
| 2009 Q1 | 19.88 Million CNY | -11.42% |
| 2009 Q3 | 31.66 Million CNY | 1.07% |
| 2009 Q4 | 52.78 Million CNY | 66.72% |
| 2009 FY | 135.66 Million CNY | 29.46% |
| 2009 Q2 | 31.32 Million CNY | 57.53% |
| 2008 FY | 104.79 Million CNY | 28.15% |
| 2008 Q4 | 22.45 Million CNY | 20.95% |
| 2008 Q3 | 18.56 Million CNY | -42.41% |
| 2008 Q2 | 32.23 Million CNY | 2.19% |
| 2008 Q1 | 31.54 Million CNY | 76.5% |
| 2007 FY | 81.76 Million CNY | 61.24% |
| 2007 Q1 | 19.64 Million CNY | 0.0% |
| 2007 Q3 | 22.56 Million CNY | 4.07% |
| 2007 Q4 | 17.87 Million CNY | -20.81% |
| 2007 Q2 | 21.68 Million CNY | 10.37% |
| 2006 FY | 50.71 Million CNY | -1.04% |
| 2005 FY | 51.24 Million CNY | 0.0% |